Antithymocyte antibody-induced coagulopathy in renal transplant recipients.
暂无分享,去创建一个
[1] A. Gaber,et al. Antithymocyte Globulin Induction in Living Donor Renal Transplant Recipients: Final Report of the TAILOR Registry , 2012, Transplantation.
[2] D. Leeser,et al. Induction Therapy in Renal Transplant Recipients , 2012 .
[3] A. Gaber,et al. A review of the evidence for use of thymoglobulin induction in renal transplantation. , 2010, Transplantation proceedings.
[4] I. Sinescu,et al. Thymoglobulin – new approaches to optimal outcomes , 2009, Journal of medicine and life.
[5] M. Pihusch. Bleeding complications after hematopoietic stem cell transplantation. , 2004, Seminars in hematology.
[6] N. Kröger,et al. Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation , 2003, Bone Marrow Transplantation.
[7] E. Holler,et al. The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation , 2002, Bone Marrow Transplantation.
[8] S. M. Lal,et al. ATGAM Associated Coagulopathy in Renal Transplant Patients: A Report of Two Unusual Cases , 1996, The International journal of artificial organs.
[9] C. Putnam,et al. A trial with heterologous antilymphocyte globulin in man. , 1969, Transplantation proceedings.
[10] T. Starzl,et al. THE CLINICAL USE OF ANTILYMPHOCYTE GLOBULIN IN RENAL HOMOTRANSPLANTATION , 1967, Transplantation.